Latest Orphan drug Stories
DUBLIN, October 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/m9tbs3/us_orphan_drug) have announced the addition of the "US
SAN DIEGO, Oct. 7, 2014 /PRNewswire/ -- DNAtrix, Inc., experts in oncolytic virus development, today announced that the U.S.
SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.
MELBOURNE, Australia, Sept.
SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
Input will help shape the role of public contributions to orphan drug approvals OTTAWA, Aug.
SAN FRANCISCO, Aug.
NESS ZIONA, Israel, August 5, 2014 /PRNewswire/ -- Atox Bio today announced that the European Commission has granted AB103 (Sodium acetate salt of the synthetic peptide
SAN DIEGO, Aug. 5, 2014 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S.
Significant company milestones include completion of the Phase 2 PUNCH(TM) CD clinical trial and FDA designation of RBX2660 as Orphan Drug and Fast Track ROSEVILLE, Minn., Aug 4, 2014
- a meat pie that is usually eaten at Christmas in Quebec